Ann: Creso Pharma Anticipates Increasing Q4 2021 Swiss Revenue, page-13

Well, if it's a fact it's not really an accusation is it. Fact: EverBlue get paid handsomely at any and all cap raises. How is it not in their best interest to continue to raise as much funds as possible, as frequently as possible? It's not an accusation when it's literally EverBlu's revenue model.

If you link me to your post I'll gladly take a look, I'm not on this forum as much anymore so won't go digging for it.

In saying that, everything anyone needs to know is in the quarterly reports anyway - it's laid out simply enough as it is without being convoluted with flashy words or headings that these guys force to the market in their announcements (apart from the section where they were so vague as to where money was being paid out, just one case I can remember and questioned at the time)